FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues
Executive Summary
FDA could help create several international coalitions to carry out its new globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors.
You may also be interested in...
Risk-Based Inspections Might Actually Be Hurting Compliant Firms
Industry exec asks FDA to help good manufacturers prove to other countries they continue to meet GMPs even if they are not inspected frequently.
Risk-Based Inspections Put Compliant Firms At Risk Of International Snags
Industry exec asks FDA to help good manufacturers prove to other countries they continue to meet GMPs even if they are not inspected frequently.
Risk-Based Inspections Put Compliant Firms At Risk Of International Snags
Industry exec asks FDA to help good manufacturers prove to other countries they continue to meet GMPs even if they are not inspected frequently.